Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justine Michaux

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Nature Biotechnology|October 16, 2019
Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomesJulien Racle, Justine Michaux, Georg Alexander Rockinger, et al.
Cancer Research|February 12, 2024
A Cluster of Evolutionarily Recent KRAB Zinc Finger Proteins Protects Cancer Cells from Replicative Stress-Induced InflammationFilipe Martins, Olga Rosspopoff, Joana Carlevaro-Fita, et al.
JCI Insight|June 21, 2019
Mass spectrometry driven exploration reveals nuances of neoepitope-driven tumor rejectionHakimeh Ebrahimi-Nik, Justine Michaux, William L Corwin, et al.
Journal for Immunotherapy of Cancer|January 12, 2022
Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinomaMona O Mohsen, Daniel E Speiser, Justine Michaux, et al.
Immunity|April 6, 2023
Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopesJulien Racle, Philippe Guillaume, Julien Schmidt, et al.
Immunity|October 10, 2023
Machine learning methods and harmonized datasets improve immunogenic neoantigen predictionMarkus Müller, Florian Huber, Marion Arnaud, et al.
Nature Cancer|May 1, 2023
The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancerAnne I Kraemer, Chloe Chong, Florian Huber, et al.
Nature Communications|March 16, 2024
Immunopeptidomics-based identification of naturally presented non-canonical circRNA-derived peptidesHumberto J Ferreira, Brian J Stevenson, HuiSong Pak, et al.
Frontiers in Immunology|August 24, 2019
A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three PatientsMichal Bassani-Sternberg, Antonia Digklia, Florian Huber, et al.
Nature Communications|November 6, 2021
Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitopeHakimeh Ebrahimi-Nik, Marmar Moussa, Ryan P Englander, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Nature Biotechnology|October 16, 2019
Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomesJulien Racle, Justine Michaux, Georg Alexander Rockinger, et al.
Cancer Research|February 12, 2024
A Cluster of Evolutionarily Recent KRAB Zinc Finger Proteins Protects Cancer Cells from Replicative Stress-Induced InflammationFilipe Martins, Olga Rosspopoff, Joana Carlevaro-Fita, et al.
JCI Insight|June 21, 2019
Mass spectrometry driven exploration reveals nuances of neoepitope-driven tumor rejectionHakimeh Ebrahimi-Nik, Justine Michaux, William L Corwin, et al.
Journal for Immunotherapy of Cancer|January 12, 2022
Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinomaMona O Mohsen, Daniel E Speiser, Justine Michaux, et al.
Immunity|April 6, 2023
Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopesJulien Racle, Philippe Guillaume, Julien Schmidt, et al.
Immunity|October 10, 2023
Machine learning methods and harmonized datasets improve immunogenic neoantigen predictionMarkus Müller, Florian Huber, Marion Arnaud, et al.
Nature Cancer|May 1, 2023
The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancerAnne I Kraemer, Chloe Chong, Florian Huber, et al.
Nature Communications|March 16, 2024
Immunopeptidomics-based identification of naturally presented non-canonical circRNA-derived peptidesHumberto J Ferreira, Brian J Stevenson, HuiSong Pak, et al.
Frontiers in Immunology|August 24, 2019
A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three PatientsMichal Bassani-Sternberg, Antonia Digklia, Florian Huber, et al.
Nature Communications|November 6, 2021
Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitopeHakimeh Ebrahimi-Nik, Marmar Moussa, Ryan P Englander, et al.
Pageof 4